Literature DB >> 16296981

No barriers to chlamydia testing in sexually active young women.

Christopher K Fairley, Jane Hocking, Jane Gunn, Marcus Y Chen.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16296981     DOI： 10.5694/j.1326-5377.2005.tb07171.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  5 in total

1.  Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors.

Authors:  Margaret M Madeleine; Tarja Anttila; Stephen M Schwartz; Pekka Saikku; Maija Leinonen; Joseph J Carter; Michelle Wurscher; Lisa G Johnson; Denise A Galloway; Janet R Daling
Journal:  Int J Cancer       Date:  2007-02-01       Impact factor: 7.396

Review 2.  Efficacy of interventions to increase the uptake of chlamydia screening in primary care: a systematic review.

Authors:  Rebecca J Guy; Hammad Ali; Bette Liu; Simone Poznanski; James Ward; Basil Donovan; John Kaldor; Jane Hocking
Journal:  BMC Infect Dis       Date:  2011-08-05       Impact factor: 3.090

Review 3.  Interventions for increasing chlamydia screening in primary care: a review.

Authors:  Samitha Ginige; Christopher K Fairley; Jane S Hocking; Francis J Bowden; Marcus Y Chen
Journal:  BMC Public Health       Date:  2007-06-04       Impact factor: 3.295

4.  Take the sex out of STI screening! Views of young women on implementing chlamydia screening in General Practice.

Authors:  Natasha L Pavlin; Rhian Parker; Christopher K Fairley; Jane M Gunn; Jane Hocking
Journal:  BMC Infect Dis       Date:  2008-05-09       Impact factor: 3.090

5.  Evaluation of Chlamydia Partner Notification Practices and Use of the "Let Them Know" Website by Family Planning Clinicians in Australia: Cross-Sectional Study.

Authors:  Rebecca J Guy; Joanne M Micallef; Julie Mooney-Somers; Muhammad S Jamil; Caroline Harvey; Deborah Bateson; Caroline van Gemert; Handan Wand; John Kaldor
Journal:  J Med Internet Res       Date:  2016-06-24       Impact factor: 5.428
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.